Warren, R., Blauvelt, A., Bagel, J., Papp, K., Yamauchi, P., Armstrong, A., Langley, R., Vanvoorden, V., De Cuyper, D., Peterson, L., Cross, N. and Reich, K. 2021. Bimekizumab Efficacy and Safety versus Adalimumab in Patients with Moderate to Severe Plaque Psoriasis: Results from a Multicenter, Randomized, Double-Blinded Active Comparator-Controlled Phase 3 Trial (BE SURE). SKIN The Journal of Cutaneous Medicine. 5, 1 (Jan. 2021), s15. DOI:https://doi.org/10.25251/skin.5.supp.15.